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Summary
Ames dwarf (Prop1df, df/df) mice are characterized by growth
hormone (GH), prolactin, and thyrotropin deficiency, remarkable
extension of longevity and increased insulin sensitivity with low
levels of fasting insulin and glucose. Plasma levels of anti-
inflammatory adiponectin are increased in df/df mice, while
pro-inflammatory IL-6 is decreased in plasma and epididymal fat.
This represents an important shift in the balance between pro-
and anti-inflammatory adipokines in adipose tissue, which was
not exposed to GH signals during development or adult life. To
determine the role of adipose tissue in the control of insulin
signaling in these long-living mutants, we examined the effects
of surgical removal of visceral (epididymal and perinephric)
adipose tissue. Comparison of the results obtained in df/df mice
and their normal (N) siblings indicated different effects of visceral
fat removal (VFR) on insulin sensitivity and glucose tolerance. The
analysis of the expression of genes related to insulin signaling
indicated that VFR improved insulin action in skeletal muscle in N
mice. Interestingly, this surgical intervention did not improve
insulin signaling in df/df mice skeletal muscle but caused
suppression of the signal in subcutaneous fat. We conclude that
altered profile of adipokines secreted by visceral fat of Ames
dwarf mice may act as a key contributor to increased insulin
sensitivity and extended longevity of these animals.
Key words: adiponectin; adipose tissue; Ames dwarf; insulin;
obesity.
Introduction
Ames dwarf (df/df) mice, discovered at Iowa State University, are
homozygous for a spontaneous mutation in the prophet of pituitary
factor-1 (prop1) gene, which codes for a transcription factor that is
responsible for pituitary development. Due to the loss-of-function
mutation, df/df mice are devoid of three cell types in the anterior
pituitary gland – somatotrophs, lactotrophs, and thyrotrophs – leading to
hormonal deficiencies of growth hormone (GH), prolactin (PRL), and
thyroid-stimulating hormone (TSH). Lack of GH leads to these mutants
having extremely low levels of insulin-like growth factor-1 (IGF-1) in
circulation and a dwarf phenotype. These mice tend to get obese as they
age, but yet live significantly longer compared with their normal (N)
siblings. Ames dwarf mice not only exhibit an increase in longevity, living
40–60% longer relative to N mice, but also an enhanced healthspan,
maintaining their youthful appearance with age. These mutants show no
signs of diabetes; they are extremely insulin sensitive with low levels of
glucose and insulin in circulation (Brown-Borg et al., 1996; Bartke et al.,
2001, 2008). Ames dwarf mice have improved cognitive function and
show no age-related decline in memory (Kinney et al., 2001) and are less
prone to cancer (Ikeno et al., 2003).
Surgically removing visceral fat (VF) depots have led to an improve-
ment in glucose tolerance and insulin sensitivity in laboratory animals
(Barzilai et al., 1999; Kim et al., 1999; Gabriely et al., 2002; Lottati
et al., 2009), supporting the idea that VF represents ‘bad’ fat and is
associated with several disease conditions including diabetes. On the
other hand, the fact that subcutaneous (SQ) fat is ‘good’ body fat was
strengthened by fat transplant experiments carried out by Tran and his
colleagues, where beneficial effects on insulin sensitivity and glucose
tolerance were achieved by transplanting SQ fat into the visceral cavity
(Tran et al., 2008).
It is well documented that adipose tissue does not just function
passively to store fat, but is an endocrine organ secreting several
biologically active peptides known as adipokines which include adipo-
nectin, TNFa, and IL-6 (Coelho et al., 2013). The level of anti-
inflammatory and antidiabetic adiponectin decreases with an increase
in obesity (Hu et al., 1996; Kern et al., 2003; El-Wakkad et al., 2013),
while that of pro-inflammatory adipokines TNFa and IL-6 increases with
the accumulation of VF (Kern et al., 2001). This shift in the secretion of
adipokines under obese conditions leads to a chronic state of low-grade
systemic inflammation.
Glucose and insulin/IGF-1 – like pathways in yeast, worms, and flies
– lead to growth as well as aging of these organisms. Mutations that
suppress or perturb these pathways lead to an increase in longevity
(Longo & Finch, 2003). These ‘longevity’ pathways are also conserved
in mammals. There are several types of mice with spontaneous
mutations or targeted disruptions of genes related to the GH/IGF-1
(somatotropic axis), including the growth hormone receptor/binding
protein knock out (GHRKO) mouse, that have extended longevity
(Bartke, 2005). The GHRKO mouse was developed as an animal model
for Laron syndrome that affects humans (Zhou et al., 1997). Human
subjects with this disorder have a mutation in the GHR gene leading to
a dwarf phenotype (Guevara-Aguirre et al., 2011). Like the animal
model, Laron dwarf humans have central obesity, low levels of IGF-1,
and high levels of GH in circulation and due to the absence of
functional GHRs, are resistant to the actions of GH. Also, these subjects
seem to be protected from cancer and diabetes (Zhou et al., 1997;
Guevara-Aguirre et al., 2011). Thus, also in humans, disruption of the
GH/IGF-1 axis could potentially extend lifespan. In contrast, transgenic
mice overexpressing GH have high circulating IGF-1 and a ‘giant’
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phenotype and are characterized by a decreased insulin sensitivity as
well as reduced longevity (Bartke et al., 2002). Humans with a
pathological excess of GH (acromegaly) are also insulin resistant
(Wasada et al., 1997) and have reduced life expectancy. Moreover, an
early-life administration of GH to long-living df/df mice leads to
reduced insulin sensitivity (Masternak et al., 2010) and a decrease in
longevity (Panici et al., 2010). Thus, GH seems to play an important
role in modulating insulin sensitivity and longevity. As mentioned
earlier, df/df mice live significantly longer compared with N mice.
However, when these mutants are subjected to calorie restriction (CR),
there is a further increase in longevity (Masternak et al., 2009). This
extension of longevity is reflected in improved insulin sensitivity as
measured by an insulin tolerance test (ITT); df/df mice are very insulin
sensitive compared with N mice, and there is a further increase in
insulin sensitivity in these mutants when calorie intake is reduced
(Masternak et al., 2009). Not only are the changes in the levels of
proapoptotic factors and key regulators of mitochondrial biogenesis
not further improved by calorie restriction in GHRKOs (Gesing et al.,
2013); interestingly, there is no further extension of longevity or an
increase in insulin sensitivity when these long-living GHRKO mice are
subjected to this same dietary intervention (Masternak et al., 2009).
Thus, there is a probable link between insulin sensitivity and longevity.
The fact that df/df mice are inclined to get obese as they age but yet
maintain high adiponectin levels in circulation (Bartke et al., 2008) and
live longer and healthier lives compared with N mice leads us to
hypothesize that VF in these mutants, developed in the absence of GH
signaling, contributes to the enhanced insulin sensitivity of df/df mice,
presumably by secreting low levels of pro-inflammatory IL-6 and
increased levels of anti-inflammatory adiponectin.
Results
Effect of VFR on glucose tolerance and insulin sensitivity
As revealed by the glucose tolerance test (GTT), only N mice that were
subjected to VFR (N-VFR) showed an improvement in glucose tolerance
with no difference in Ames dwarf mice after VFR (df/df VFR) (Fig. 1A, B).
There was a significant difference in blood glucose levels between N
mice in the sham-operated and VFR groups at the following time points:
30 min (P = 0.0436), 45 min (P = 0.0274), and 60 min (P = 0.0249).
The difference in blood glucose between N-sham and df/df-sham mice
was significant only at 45 min (P = 0.0079), 60 min (P = 0.0104), and
120 min (P = 0.0100) time points. Interestingly, at time 0 min, mice in
the df/df-sham group had a significantly lower blood glucose level than
mice in the df/df-VFR group (P = 0.0028) (Fig. 1A). Additional analysis of
area under the curve (AUC) indicated improved glucose tolerance in N
VFR, df/df sham, and df/df VFR when compared to N-sham mice
(P = 0.0086, P = 0.0125, and P = 0.0122, respectively) (Fig. 1B), while
glucose tolerance in df/df VFR did not differ from values measured in df/
df-sham animals.
As expected, df/df-sham mice were very insulin sensitive compared
with N-sham mice. During the insulin tolerance test (ITT), blood glucose
levels (expressed as percent of baseline) differed between df/df and N
animals at 15 min (P = 0.0381), 30 min (P = 0.0038), 45 min
(P = 0.0090), and 60 min (P = 0.0034). The effect of VFR on insulin
sensitivity in df/df mice was statistically significant only at the 15-min
time point (P = 0.0297). There was significant genotype/intervention
interaction for GTT and ITT as determined by repeated-measures ANOVA
test (P = 0.0310 and P = 0.0006 respectively) (Fig. 1C). Area under the
curve analysis also indicated increased insulin sensitivity of df/df-sham
and df/df-VFR mice compared with N-sham animals (P = 0.0041 and
P = 0.0122, respectively). There was also a trend for decreased insulin
sensitivity in df/df VFR compared with df/df-sham mutants which did not
reach statistical significance (P = 0.0615) (Fig. 1D).
Two-way ANOVA analysis did not reveal significant effects of either
genotype or intervention (VFR) on fasting blood glucose levels (FBG);
however, there was significant genotype and intervention interaction
(P < 0.0056). Following two-way ANOVA, t-test indicated significantly
lower levels of FBG in df/df mice as compared to N mice (P = 0.0014).
Although VFR did not have any effect on FBG of N mice, this surgical
intervention led to a significant increase in FBG of df/df mice
(P = 0.0020) (Fig. 1E).
There was a significant effect of genotype on insulin levels as
revealed by two-way ANOVA (P < 0.0024). Further analysis indicated
that plasma insulin levels were significantly lower in the mutants
compared with N mice (P = 0.0125). Surgically removing VF depots led
to a significant decrease in circulating insulin levels in N mice only
(P = 0.0233) with no change in df/df mice (Fig. 1F). Two-way ANOVA
of the homeostatic model assessment (HOMA) score indicated signif-
icant genotype effect (P < 0.0058). Further analysis revealed that df/df-
sham mice were markedly more insulin sensitive than the N-sham mice
(P = 0.0153). Also, in parallel with decreased plasma insulin levels, VFR
significantly improved insulin sensitivity only in N mice (P = 0.0306)
(Fig. 1G).
Effect of VFR on insulin signaling in skeletal muscle
Two-way ANOVA analysis of the expression levels of genes involved in
insulin signaling pathway in skeletal muscle revealed significant interac-
tion between genotype and intervention for mRNA levels of insulin
receptor (IR), insulin receptor substrate-2 (IRS-2), and Akt2 (P < 0.0223,
P < 0.03 and P < 0.0222 respectively) and a similar trend for glucose
transporter 4 (GLUT4) (P < 0.056). Moreover, expression of peroxisome
proliferator-activated receptor gamma (PPARc) was significantly affected
by both genotype and intervention (P < 0.0196 and P < 0.0043,
respectively) without any significant level for interaction between
genotype and intervention (P < 0.0867). Further analysis of transcript
levels of IR, IRS2, phosphoinositide 3-kinase (PI3K), Akt2, GLUT4, PPARc,
and peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC1a) showed significant increase in skeletal muscle of
N-VFR mice compared with N-sham group (P = 0.0054, P = 0.0046,
P = 0.0032, P = 0.0014, P = 0.0085, P = 0.0002, and P = 0.0187,
respectively) with no alterations in df/df-VFR when compared to df/df-
sham mutants (Fig. 2).
Effect of VFR on the expression of insulin signaling genes in
SQ fat
Two-way ANOVA analysis of real-time PCR data indicated significant
effects of VFR on the gene expression levels of IR, IRS1, and PGC1a
(P < 0.03; P < 0.01; and P < 0.028, respectively). This analysis also
indicated significant genotype effect on the expression of IRS1 in SQ fat
(P < 0.0003). Additional analysis following our initial findings by two-
way ANOVA indicated a decrease in the expression of IR, IRS-1, PI3K,
Akt2, GLUT4, and PGC1a genes in SQ fat after VFR in df/df mice only
(P = 0.0057, P = 0.0115, P = 0.0362, P = 0.0098, P = 0.0326, and
P = 0.0428, respectively) without any alterations in N animals subjected
to the same surgical procedure. Moreover, the mRNA expression of IR
and IRS-1 was higher in df/df-sham mice compared with N-sham mice
(P = 0.0336 and P = 0.0019 respectively) (Fig. 3).
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Differential gene expression and secretory profile of visceral
adipose tissue and circulating adipokine levels in df/df vs. N
mice
In this experiment, we used epididymal fat (EF) as a main source of
visceral fat, collected from animals in the sham-operated group. The
relative expression levels of IR, IRS-1, and PGC1a were significantly
higher in EF from df/df mice when compared to the same fat depot from
N mice (P = 0.0209, P = 0.0221, and P = 0.0033 respectively) (Fig. 4A,
B, C). In contrast, the RNA expression level of pro-inflammatory TNFa
was down-regulated in EF of df/df mice relative to EF from N mice
(P < 0.0114) (Fig. 4D). As documented previously in the literature, Ames
dwarf mice had significantly higher levels of adiponectin in circulation
(P = 0.0031), although VFR did not alter circulating levels of this
adipokine in either group of mice (Fig. 4E). More direct analysis of
adiponectin at the protein level by ELISA in epididymal (EF), perirenal
(PR), and subcutaneous (SQ) fat pads, dissected from a second cohort of
male mice as mentioned in materials and methods, did not show any
differences between df/df and N mice (~1 year old) (Fig. 4F).
However, EF and PR fat had higher adiponectin protein levels as
compared to SQ fat in N mice (P = 0.0038 and P = 0.0139 respectively).
Also, the EF depot in df/df mice had higher levels of adiponectin protein
compared with SQ fat of these mutants (P = 0.0489) (Fig. 4F). Bio-Plex
analysis revealed significantly lower protein levels of IL-6 in EF of df/df
Glucose tolerance  test (GTT)
0 min 15 min 30 min 45 min 60 min120 min
0
100
200
300
400
Time
G
lu
co
se
 (m
g 
dL
–1
)
*
$
$ # $#
#
Insulin tolerance test
0 min 15 min 30 min 45 min 60 min
0
10
20
30
40
50
60
70
80
90
100
110
N sham
N VFR
Df sham
Df VFR
Time
B
lo
od
 g
lu
co
se
 (p
er
ce
nt
 o
f b
as
el
in
e)
*
# # #
#
B
lo
od
 g
lu
co
se
 (m
g 
dL
–1
)
N 
sh
am
N 
VF
R
df/
df 
sh
am
df/
df 
VF
R
0
50
100
150
200
a
a b
a
Fasting blood glucose Plasma insulin
ng
 m
L–
1
N 
sh
am
N 
VF
R
df/
df 
sh
am
df/
df 
VF
R
0.0
0.2
0.4
0.6
0.8
1.0
a
b
c c
HOMA
H
O
M
A
 s
co
re
N 
sh
am
N 
VF
R
df/
df 
sh
am
df/
df 
VF
R 
0
1
2
3
4
5 a
b
c c
ITT
A
re
a 
un
de
r t
he
 c
ur
ve
 (A
U
C
)
N-sham N-VFR DF-sham DF-VFR
0
1000
2000
3000
4000
5000 a
b
b
a
GTT
A
re
a 
un
de
r t
he
 c
ur
ve
 (A
U
C
)
N-sham N-VFR DF-sham DF-VFR
0
10 000
20 000
30 000 a
b b b
(a) (c)
(b)
(e) (f) (g)
(d)
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mice relative to the N mice (P = 0.0308) (Fig. 4G). Parallel to decreased
protein expression of IL-6 in EF of df/df mice, these mutants also had low
levels of this pro-inflammatory adipokine in circulation relative to control
mice (~1 year old) (P = 0.0495) (Fig. 4H).
Discussion
Ames dwarf mice tend to get obese as they age; however, they not only
live longer, but also show an increase in healthspan, with delayed signs
of age-related diseases including diabetes. Thus, we believe that the VF
depots in these mutants are functionally distinct from the same fat
depots in N mice and are beneficial, rather than detrimental, to the
overall health of these mutant mice.
Growth hormone-deficient df/df mice share many physiological and
endocrine characteristics with GH-resistant GHRKO mice. Surgical
removal of VF depots in GHRKO mice strengthened the idea that these
fat depots, developed in the absence of GH signaling, have beneficial
effects (Masternak et al., 2012). This intervention improved insulin
sensitivity only in control mice, with opposite effects in GHRKO mutants
(Masternak et al., 2012).
As expected, df/df mice had improved glucose tolerance and insulin
sensitivity, as indicated by GTT and ITT, compared with N mice. However,
the surgical removal of VF depots improved glucose tolerance only in the
control mice. There was no significant effect of VFR on insulin sensitivity
on either group of mice, as measured by ITT although numerically insulin
sensitivity was increased in N mice and reduced in the dwarfs. The
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HOMA score, which is a measure of insulin sensitivity, calculated by the
formula (insulin 9 glucose)/22.5, with lower values pointing to higher
insulin sensitivity, indicated that VFR improved insulin sensitivity only in N
mice, with a parallel decrease in plasma insulin levels in these controls.
Also, in conjunction with ITT results, HOMA scores revealed that df/df
mice were much more insulin sensitive compared with N mice. One
possible explanation for the lack of a significant effect of VFR on insulin
sensitivity measured by ITT is that this test is accompanied by a high risk
of inducing hypoglycemic conditions in the test mice, which induces
endogenous glucose production and glycogenolysis to maintain eugly-
cemic levels, thus hampering test results. Given the small body size of
these mutant dwarfs, it is technically not feasible to perform the more
sensitive hyperinsulinemic-euglycemic clamp study as a measure of
insulin sensitivity.
Even though there was a decrease in plasma insulin levels of N mice
that were subjected to VFR, there was no change in blood glucose levels
of this group of mice. This indicates that the decreased levels of insulin
upon VFR are sufficient to maintain euglycemic levels in N mice in the
VFR group. However, this surgical intervention led to an increase in
blood glucose in df/df mice with no change in plasma insulin levels. Thus,
surgical removal of VF depots in N mice improved whole-body insulin
sensitivity, supporting previous data, as mentioned before, that show
that these fat pads represent ‘bad’ body fat; but in df/df mice, removal
of the same fat depots negatively affects blood glucose levels,
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suggesting that VF in the mutants plays a positive role in maintaining
whole-body insulin sensitivity.
Skeletal muscle and adipose tissue are two of the most insulin-
responsive organs. Surgically removing VF depots led to an up-regulation
of several genes involved in the insulin signaling pathway in the skeletal
muscle of N mice; in turn, this procedure led to a decrease in the
expression of these genes in SQ fat of df/df mice. This decreased
expression of the insulin signaling genes, including the glucose trans-
porter GLUT4, in SQ fat and the absence of functionally beneficial VF
(due to VFR) in the df/df mice could probably lead to decrease glucose
disposal and a corresponding increase in blood glucose.
The up-regulation of some of the basic players involved in insulin
signaling in skeletal muscle of N, but not df/df mice, subjected to VFR
indicates that only normalmice benefit from this surgical intervention. The
increased mRNA expression of insulin receptor (IR), insulin receptor
substrate-2 (IRS-2), phosphoinositide 3-kinase (PI3K), Akt 2, and GLUT4 in
the skeletal muscle of the N mice with visceral fat removed probably
contributes to the increased insulin sensitivity seen in these animals which
corresponds with previous findings in normal controls from a different
strain (Masternak et al., 2012). However, to fully understand the effects of
insulin action in skeletal muscle and other insulin target organs, further
functional analysis of the levels of phosphoproteins corresponding to the
analyzed genes needs to be performed in future as was carried out in our
studies of VFR in GHRKO mice (Masternak et al., 2012).
Peroxisome proliferator-activated receptors (PPARs) are ligand-depen-
dent transcription factors activated by different ligands, such as fatty
IR
Epididymal fat
R
el
at
iv
e 
ex
pr
es
si
on
N 
sh
am
df/
df 
sh
am
Epididymal fat
N 
sh
am
df/
df 
sh
am
Epididymal fat
N 
sh
am
df/
df 
sh
am
0.0
0.5
1.0
1.5
2.0
a
b
IRS1
R
el
at
iv
e 
ex
pr
es
si
on
0.0
0.5
1.0
1.5
2.0
2.5
a
b
PGC1
R
el
at
iv
e 
ex
pr
es
si
on
0
2
4
6
8
a
b
TNF
Epididymal fat
R
el
at
iv
e 
ex
pr
es
si
on
N 
sh
am
df/
df 
sh
am
0.0
0.5
1.0
1.5
a
b
Plasma adiponectin
ng
 m
L–
1
N 
sh
am
N 
VF
R
df/
df 
sh
am
df/
df 
VF
R
0
2000
4000
6000
8000
a
a
b b
EF
 N
EF
 df
/df
PR
 N
PR
 df
/df
SQ
 N
SQ
 df
/df
0
500
1000
1500
2000 a
a
a
a,b
b
b
Adiponectin levels in different fat pads IL-6
Epididymal fat
N 
sh
am
df/
df 
sh
am
0.0
0.2
0.4
0.6 a
b
IL-6
Serum
pg
 m
L–
1
pg
 m
L–
1
ng
 m
L–
1
N
df/
df
0.0
0.2
0.4
0.6
a
b
(a) (b)
(d) (e)
(c)
(f) (g) (h)
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represent statistical significance (P < 0.05)
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acids, and are targets of the antidiabetic class of drugs known as
thiazolidinediones (TZDs). These nuclear receptors, once activated, form
heterodimers with retinoid X receptors (RXRs) and bind to peroxisome
proliferator response elements (PPREs) in the enhancers of target genes
leading to activation of transcription of these genes (Masternak &
Bartke, 2007). PPARc is highly expressed in white adipose tissue;
however, several insulin-sensitive tissues also express this transcription
factor. Skeletal muscle PPARc increases glucose uptake and utilization
(Auwerx et al., 2003), and optimum expression of this nuclear receptor
seems to play an important role in maintaining whole-body insulin
sensitivity. Muscle-specific PPARc knockout mice exhibit an increase in
adiposity and develop insulin resistance, but are still responsive to TZDs
(Norris et al., 2003). On the other hand, CR – an intervention that
improves whole-body insulin sensitivity – led to a decrease in the
expression of PPARc in skeletal muscle of GHRKO mice (Masternak &
Bartke, 2007). In the present study, VFR led to increased transcript levels
of PPARc, as well as its coactivator – PGC1a in skeletal muscle of N mice
only; thus, it probably contributes to increased insulin sensitivity seen in
this group of mice.
The effect of VFR on SQ fat was studied by qPCR analyses of the
expression of genes involved in insulin signaling in this fat depot. The
decrease in mRNA levels of IR, IRS-1, PI3K, Akt 2, and GLUT4 in SQ
fat of df/df mice in the VFR group may, in part, contribute to
decreased insulin signaling in this fat depot, and a corresponding
increase in blood glucose seen in these long-living mice. Mice with
adipose-specific knockout of PGC1a are characterized by insulin
resistance when fed a high-fat diet (Kleiner et al., 2012), emphasizing
the contribution of PGC1a to maintaining insulin sensitivity. There was
a decrease in the expression of PGC1a in SQ fat of df/df -VFR mice.
Even though there was no significant change in the expression of
PPARc in this fat depot upon VFR, the decrease in PGC1a transcript
levels could potentially lead to a decrease in insulin sensitivity in
df/df-VFR mice. The expression of IR and IRS-1 at the mRNA level was
higher in df/df mice compared with N mice in the sham-operated
groups, which could contribute to the enhanced insulin sensitivity of
these mutant dwarfs.
To understand how VF in df/df mice contributes to enhanced insulin
sensitivity of these mutants, we analyzed the expression of insulin
signaling genes and adipokine levels in EF of df/df and N mice. The
expression of IR, IRS-1, and PGC1a was increased in the VF depot of
df/df mice compared with the controls. Moreover, mRNA levels of
pro-inflammatory TNFa were significantly decreased in EF of df/df mice.
Moreover, the levels of IL-6 protein, another pro-inflammatory adipo-
kine, were significantly lower in EF depot of these mutants. Protein
levels of adiponectin, which has anti-inflammatory and antidiabetic
properties, were higher in this VF pad compared with SQ fat of df/df
mice. Concomitant with decreased expression of IL-6 and increased
expression of adiponectin proteins in EF of df/df mice, these mutant
dwarfs also had low levels of IL-6 and high levels of adiponectin in
circulation. However, VFR did not significantly alter plasma adiponectin
levels in either group of mice. One possible explanation of this
observation is the fact that the removal of EF and PR fat depots causes
an increase in the secretion of adiponectin by intact SQ fat depots as a
compensatory mechanism. Thus, the present findings may explain the
contribution of EF to improved insulin signaling in df/df mice. There
were no significant differences in the protein expression of adiponectin,
as measured by ELISA, between the major VF depots (EF and PR fat) or
SQ fat between the two groups of mice. Also, EF and PR fat depots of
N mice had a higher protein level of adiponectin as compared to SQ
fat. Several studies support the idea that VF produces adiponectin and
thus determines the level of adiponectin in circulation (Halleux et al.,
2001; Motoshima et al., 2002; Cnop et al., 2003). In the current study,
we used healthy, nonobese mice for determining physiological adipo-
nectin levels in different fat pads rather than dysregulation in the
production of adiponectin associated with genetic or dietary induction
of obesity. Under obese conditions, the different fat depots would have
a differential secretory profile, with VF releasing more pro-inflamma-
tory adipokines and less adiponectin.
Even though df/df mice share several characteristics with GHRKO
mice, these two groups of mutant mice exhibit traits exclusive to their
genotypes. Most importantly, cells of the df/df mouse do express the
GHR, but due to the prop1 mutation, somatotrophs do not produce GH.
Conversely, cells of the GHRKO mouse are characterized by the absence
of functional GHRs, but there is pituitary production of GH. Thus, a state
of GH deficiency or GH resistance can be observed in the df/df and
GHRKO mice, respectively.
Summing up, our present results suggest that EF (one of the major
VF depots in mice), developed in the absence of GH signals, has
decreased mRNA levels of proinflammatory cytokines – TNFa and IL-6
with parallel increase in the levels of anti-inflammatory adiponectin.
These alterations may contribute to increased whole-body insulin
sensitivity and enhancement of insulin action in skeletal muscle of
these long-living mutant mice. However, the expression of insulin
signaling genes by measurements of the mRNA levels should be
followed in the future by determinations of the levels of the
corresponding proteins and phosphoproteins. These analyses were
not carried out in the present study due to limited amount of tissues
that could be dissected from these diminutive animals. However,
based on presented results, we can conclude that at the very least, VF
in df/df mice does not negatively affect insulin signaling and is not
detrimental to the overall health of these animals. These new data
obtained from GH-deficient Ames dwarf mice as well as previously
published findings in GH-resistant Laron dwarf mice suggest that the
impact of reduced somatotropic axis activity on insulin signaling and
inflammation importantly contributes to delayed aging and extended
healthspan and longevity of these remarkably long-lived mutants
(Fig. 5).
Fig. 5 Proposed mechanisms of extended longevity in df/df mice. GH-deficient df/
df mice are very insulin sensitive with low levels of glucose and insulin in
circulation. These mutant mice also have high levels of adiponectin and decreased
levels of IL-6 in circulation. Due to GH deficiency, df/df mice have very low IGF-1 in
circulation and, thus, a decreased incidence of cancer. All these findings taken
together could lead to a delayed rate of aging and, thus, an extension of longevity
of df/df mice.
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Materials and Methods
Experimental animals
Breeding was carried out as described previously (Bartke et al., 2001).
Ames dwarf and control male mice used in this study were developed by
crossing normal heterozygous (df+/) female with homozygous Ames
dwarf male mice; thus, 50% of the progeny were mutant. The prop1
mutation was maintained on a heterogeneous background. All mice
were maintained in temperature-controlled conditions (20–22 °C) under
12-h light/12-h dark cycles. They had free access to drinking water and
standard laboratory chow diet. Ames dwarf mice were weaned at
41 days, while N mice were weaned at the usual 21 days. Animals were
provided ad libitum access to food with nutritionally balanced diet
(Rodent Laboratory Chow 5001; 23.4% protein, 4.5% fat, 5.8% crude
fiber; LabDiet PMI Feeds, Inc., St. Louis, MO, USA).
Visceral fat removal
Ames dwarf and N male mice, 3–6 months old, were categorized into
two groups: visceral fat removal (VFR) and sham-operated, respectively.
All surgical procedures were carried out under ketamine/xylazine
anesthesia following a previously established protocol (Masternak et al.,
2012). Mice in the sham-operated group had their VF mobilized, but not
removed.
Animals for analysis of fat adiponectin and serum IL-6 levels
Animals used for analyzing the levels of adiponectin in different fat pads
and IL-6 in serum were about 1-year-old males. After an overnight fast,
df/df (n = 10) and N (n = 10) mice were anesthetized with isofluorane.
Blood was collected by cardiac puncture. Mice were sacrificed by cervical
dislocation. Different fat pads (EF, PR, and SQ) were collected and snap-
frozen in liquid nitrogen. Proteins were extracted from these fat depots
before storing the tissues at 80 °C.
Analysis of glucose tolerance and whole-body insulin
sensitivity
Approximately a month after surgery, mice (n = 16–20) were subjected
to a glucose tolerance test (GTT) to determine their ability to clear
blood glucose. After overnight fasting, body weights were determined
and the tail was snipped to collect blood samples. A baseline blood
glucose measurement (0 min) was made using a standard glucometer.
Then, the mice were injected intraperitoneally with glucose (2 g
glucose per kg body weight), and blood glucose levels were measured
at defined time points (15 min, 30 min, 45 min, 60 min, and
120 min). Following GTT, 100 animals from each group were randomly
selected to perform an insulin tolerance test (ITT) to determine
sensitivity to injected insulin at the whole-body level. For this
experiment, mice were not subjected to standard 4-h fasting before
the test; however, the food was removed from the cages in the
morning when the animals were weighed and then the baseline blood
glucose (0 min) was analyzed. This method was modified based on our
previous work with insulin-sensitive df/df and GHRKO mice (26) when
we observed that subjecting these mice to 4-h fasting before ITT
caused glucose levels dropping below 20 mg dL1. Following our
observations, we had to start to perform ITT testing with food removal
during body weights collection initially before the insulin injection
which eliminated previous hypoglycemia problems. After initial blood
glucose collection, the mice were intraperitoneally injected with insulin
(1 IU insulin per kg body weight). Blood glucose levels were checked at
specific time points (15 min, 30 min, 45 min, and 60 min). Animals
not responding to the injected insulin as indicated by an increase in
glucose level after insulin injection were excluded from final analysis as
nonresponders which resulted in n = 6–9 animals per group as a final
count for ITT.
Insulin stimulation and tissue collection
Three months after surgery, mice were fasted overnight and then
anesthetized with ketamine/xylazine. Blood was collected by cardiac
puncture. In each group of mice, animals (approximately 50%) were
injected with either a high dose of insulin (10 IU insulin per kg body
weight) or saline (control) via the inferior vena cava to stimulate insulin
signaling in target organs. Exactly 2 min after injection, mice were
sacrificed by cervical dislocation, and tissues were collected and snap-
frozen in liquid nitrogen and stored at 80 °C till further analysis. At the
time of tissue collection, no visible regrowth of fat was seen in the
animals that had undergone VFR.
RNA extraction from frozen tissue
RNA was extracted from approximately 50 mg of frozen skeletal
muscle and adipose tissues using the miRNeasy mini kit (Qiagen,
Valencia, CA, USA) according to the manufacturer’s protocol. Samples
were homogenized using zirconium oxide beads (1.0 mm for skeletal
muscle and 0.5 mm for adipose tissue) using the Bullet Blender
Homogenizer BBX24 (Next Advance, Averill Park, NY, USA) (Skeletal
muscle: speed 10, 3 min; adipose tissue: speed 8, 3 min). RNA
extraction from adipose tissue involved the additional step of centri-
fuging the samples at 12 000 9 g for 10 min at 4 °C, after which the
upper lipid layer was excluded and only the infranatant was transferred
to a new tube. Pure RNA was eluted using 50 lL and 30 lL nuclease-
free water (provided in the kit) for skeletal muscle and adipose tissue
samples, respectively. The concentration and purity of the eluted RNA
samples were determined using the Take3 plate and the Epoch plate
reader (BioTek, Winooski, VT, USA). RNA samples with A260/
A280 < 1.9 were re-extracted. Extracted RNA samples were stored at
80 °C until further use.
cDNA synthesis
Complementary DNA was synthesized from extracted RNA samples
using iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) (Skeletal
muscle and epididymal fat) or EasyScript PlusTM cDNA Synthesis Kit
(Applied Biological Materials, Richmond, BC, Canada) (Subcutaneous fat)
according to the manufacturer’s protocol. One microgram of RNA was
used per reaction.
Quantitative real-time polymerase chain reaction (qPCR)
Relative gene expression was analyzed by qPCR using Fast SYBR Green
Master Mix (Applied Biosystems, Foster City, CA, USA) on 7900 HT fast
real-time PCR system (Applied Biosystems) with the following run
conditions: enzyme activation at 95 °C for 20 s, denaturation at 95 °C
for 1 s, and annealing/extension at 62 °C for 20 s. Additionally, a melt
curve was included for each run. Forward and backward primer
sequences used are as in Table 1. Results were analyzed as detailed
previously (Masternak et al., 2005).
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Protein extraction from frozen tissue
Total proteins were extracted from skeletal muscle and adipose tissues
using T-PER Tissue Protein Extraction Reagent (with proteases and
phosphatases inhibitors) (Thermo Scientific, Waltham, MA, USA).
Samples were homogenized in the extraction buffer using the Bullet
Blender homogenizer, as mentioned earlier. After centrifugation at
12 000 9 g for 15 min at 4 °C, the layer below the fat was collected
into a new tube and centrifuged again. The relatively fat-free protein
extract was then quantified using the BCA assay (Thermo Scientific). For
the quantification assay, protein samples were diluted 1:10 with T-per.
Analysis of insulin and adiponectin levels
Ultra sensitive mouse insulin ELISA kit (Crystal Chem, Downers Grove, IL,
USA) was used for the analysis of insulin in plasma. Mouse adiponectin
ELISA kits (Invitrogen, Grand Island, NY, USA) were used to analyze the
levels of adiponectin in plasma and different fat pads. All procedures
were performed according to the manufacturer’s protocol. For analyzing
adiponectin levels in fat tissue, extracted proteins were first adjusted to a
concentration of 0.5 lg lL1 in a total volume of 60 lL in the same
extraction buffer (T-PER) and then diluted to a concentration of
0.0025 lg lL1 using the diluent buffer (1X) from the kit. The protocol
provided in the kit was then followed.
Bio-Plex ProTM Assay for IL-6 levels in serum
Interleukin-6 levels in serum of df/df and N mice were detected using the
Bio-plex assay (Bio-Rad) according to the provided protocol.
Statistical analysis
Analyses were performed by two-way ANOVA test and Student’s t-test
within groups when warranted. All statistics and graphs were conducted
using Prism 5 (GraphPad Software, San Diego, CA, USA). Alpha is set to
0.05. Values are reported as mean  standard error of the mean (SEM)
throughout the figures and text.
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